RecallWatchUSA

Home / Categories / Drugs

Drugs Recalls

17,897 recalls, newest first.

November 13, 2019DrugsFDA
Basic Reset Inc. recalls BIOGENYX True Full Spectrum CBD Oil Cinnamon, 1 fl. oz. (30 mL) bottle, 750 mg, Distributed by: Biogenyx, Inc. Henderson
Hazard: Marketed without an Approved NDA/ANDA
November 13, 2019DrugsFDA
Basic Reset Inc. recalls BIOGENYX True Full Spectrum CBD Oil Natural Flavor, 1 fl. oz. (30 mL) bottle, 2400 mg, Distributed by: Biogenyx, Inc. He
Hazard: Marketed without an Approved NDA/ANDA
November 13, 2019DrugsFDA
Basic Reset Inc. recalls BIOGENYX True Full Spectrum CBD Oil Wintergreen, 1 fl. oz. (30 mL) bottle, 750 mg, Distributed by: Biogenyx, Inc. Hender
Hazard: Marketed without an Approved NDA/ANDA
November 13, 2019DrugsFDA
Basic Reset Inc. recalls Basic Reset CBD Reset 2400, True Full Spectrum Natural (unflavored), 2400 mg CBD, 1 fl. oz. (29 mL) bottle, Distributed
Hazard: Marketed without an Approved NDA/ANDA
November 13, 2019DrugsFDA
Basic Reset Inc. recalls Basic Reset CBD Reset 750 True Full Spectrum Natural Flavor 750 mg CBD 1 fl. oz. (30 mL) bottle, Distributed by: Basic R
Hazard: Marketed without an Approved NDA/ANDA
November 13, 2019DrugsFDA
Basic Reset Inc. recalls Basic Reset CBD Reset 750 True Full Spectrum Cinnamon, 750 mg CBD, 1 fl. oz. (30 mL) bottle, Distributed by: Basic Reset
Hazard: Marketed without an Approved NDA/ANDA
November 13, 2019DrugsFDA
Basic Reset Inc. recalls Basic Reset CBD Reset 750 True Full Spectrum Wintergreen, 750 mg CBD, 1 fl. oz. (30 mL) bottle, Distributed by: Basic Re
Hazard: Marketed without an Approved NDA/ANDA
November 13, 2019DrugsFDA
Basic Reset Inc. recalls Nuovi Firming Masque, Renew and Reset, 2 fl. oz. 59 mL bottle, Made in USA exclusively for Basic Reset 260 W. Main St.,
Hazard: Marketed without an Approved NDA/ANDA
November 13, 2019DrugsFDA
Basic Reset Inc. recalls Basic Reset Nuovi Skin Toner, Refined Ionyte, 4 FL. OZ., 118.3 mL bottle, Distributed by: Basic Reset Hendersonville, TN
Hazard: Marketed without an Approved NDA/ANDA
November 13, 2019DrugsFDA
Basic Reset Inc. recalls Miracle Facelift Masque, All Natural, The Miracle in a Bottle, 2 fl. oz./60 mL bottle, Kim Kaufman Productions Nashville
Hazard: Marketed without an Approved NDA/ANDA
November 13, 2019DrugsFDA
Basic Reset Inc. recalls Basic Reset Earth Wash Cleaner and Personal Care, Eco Friendly, Non Toxic, 2 fl.oz. bottle, Distributed by: Basic Reset
Hazard: Marketed without an Approved NDA/ANDA
November 13, 2019DrugsFDA
Mylan Pharmaceuticals Inc. recalls Alprazolam Tablets, USP 0.5 mg, 500-count bottles, Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV
Hazard: Presence of Foreign Substance
November 13, 2019DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Ranitidine Tablets, USP 150 mg, NDC 57896-717 (GeriCare) OTC
Hazard: CGMP Deviations: Presence of NDMA impurity detected in product.
November 13, 2019DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Ranitidine Tablets, USP 150 mg, a.) 24 count bottles (NDC 63868-480-24), b.) 50-count bottles (NDC 63868-480-50) (CDMA)
Hazard: CGMP Deviations: Presence of NDMA impurity detected in product.
November 13, 2019DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Ranitidine Tablets, USP 75 mg, a.) 30- count bottles (NDC 0363-0131-30), b.) 80-count bottles (NDC 0363-0131-80) (Walgr
Hazard: CGMP Deviations: Presence of NDMA impurity detected in product.
November 13, 2019DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Dr. Reddy's Ranitidine Tablets, USP 150 mg, 24 count bottles, NDC 55111-404-34 (OTC)
Hazard: CGMP Deviations: Presence of NDMA impurity detected in product.
November 13, 2019DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Dr. Reddy's Ranitidine Tablets, USP 75 mg, 60 count bottles, NDC 55111-131-60, (OTC)
Hazard: CGMP Deviations: Presence of NDMA impurity detected in product.
November 13, 2019DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Dr. Reddy's Ranitidine Capsules, USP 300 mg, a.) 30 count bottles (NDC 55111-130-30) b.) 100 count bottles (NDC 55111-13
Hazard: CGMP Deviations: Presence of NDMA impurity detected in product.
November 13, 2019DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Ranitidine Tablets, USP 150 mg, 40 count bottles, NDC 11673-849-40 (Target) OTC.
Hazard: CGMP Deviations: Presence of NDMA impurity detected in product.
November 13, 2019DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Ranitidine Tablets, USP 75 mg, NDC 57896-715 (GeriCare) OTC.
Hazard: CGMP Deviations: Presence of NDMA impurity detected in product.
November 13, 2019DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Ranitidine Tablets, USP 150 mg, a.) 24 count bottles (NDC 71713-203-02), b.)95 count bottles (NDC 71713-203-05) (Thirty
Hazard: CGMP Deviations: Presence of NDMA impurity detected in product.
November 13, 2019DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Ranitidine Tablets, USP 150 mg, a.) 95 count bottles (NDC 43598-808-62), b.) 220 count bottles (NDC 43598-808-65) (HCA)
Hazard: CGMP Deviations: Presence of NDMA impurity detected in product.
November 13, 2019DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Ranitidine Tablets 75 mg, a.) 30 count bottles (NDC 63868-482-30), 60 count bottles (NDC 63868-482-60) (CDMA) OTC
Hazard: CGMP Deviations: Presence of NDMA impurity detected in product.
November 13, 2019DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Ranitidine Tablets, USP 75 mg 30 count bottles (NDC 30142-131-30) (Kroger)
Hazard: CGMP Deviations: Presence of NDMA impurity detected in product.
November 13, 2019DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Ranitidine Tablets, USP 75 mg, a.) 30 count bottles (NDC 69842-871-30) b.) 80 count bottles (NDC 69842-871-80) c.)160 c
Hazard: CGMP Deviations: Presence of NDMA impurity detected in product.
November 13, 2019DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Ranitidine Tablets, USP 150 mg, a.) 24 count bottles (NDC 30142-505-34), b.) 50 count bottles (NDC 30142-505-50) (Kroger
Hazard: CGMP Deviations: Presence of NDMA impurity detected in product.
November 13, 2019DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Ranitidine Tablets, USP 150 mg, a.) 65 count bottles (NDC 49035-404-61) b.) 130 count bottles (NDC 49035-404-13) c.) 220
Hazard: CGMP Deviations: Presence of NDMA impurity detected in product.
November 13, 2019DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Ranitidine Tablets, USP 150 mg, a.) 24 count bottles (NDC 0363-0010-34), b.) 65 count bottles (NDC 0363-0010-61) , c.) 9
Hazard: CGMP Deviations: Presence of NDMA impurity detected in product.
November 13, 2019DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Ranitidine Tablets, USP 150 mg, 190 count bottles (2x95) Tray (Sam's Club) OTC, NDC 150062076 UPC Code 078742089720
Hazard: CGMP Deviations: Presence of NDMA impurity detected in product.
November 13, 2019DrugsFDA
Dr. Reddy's Laboratories, Inc. recalls Dr. Reddy's: Ranitidine Capsules 150 mg, Rx a.) 60 count bottles (NDC 55111-129-60) b.) 500 count bottles (NDC 55111-12
Hazard: CGMP Deviations: Presence of NDMA impurity detected in product.